Saratoga Health & Biotechnology Portfolio Fund Class C (SHPCX)

Fund Assets	12.04M
Expense Ratio	3.487%
Min. Investment	$250
Turnover	22.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 9, 2025

Previous Close	16.44
YTD Return	17.93%
1-Year Return	23.16%
5-Year Return	40.84%
52-Week Low	13.39
52-Week High	16.87
Beta (5Y)	0.70
Holdings	29
Inception Date	Jan 18, 2000

About SHPCX

Saratoga Health & Biotechnology Portfolio Fund Class C is a sector-focused mutual fund that primarily invests in the healthcare and biotechnology industries. Its main objective is the preservation and appreciation of capital through diversified holdings across U.S. and, to a lesser extent, foreign companies engaged in pharmaceuticals, medical devices, biotechnology, healthcare services, and related sub-sectors. Managed by Oak Associates LTD, the fund employs a top-down investment approach, targeting long-term economic trends to identify high-quality companies with strong fundamentals and growth potential within the healthcare sector. The portfolio is actively managed, with a significant allocation to large- and mid-cap companies but also includes exposure to small and micro-cap firms. This fund is designed for investors seeking specialized exposure to the evolving healthcare and biotech landscapes, sectors that play a vital role in advancing global health solutions and medical innovation. Saratoga Health & Biotechnology Portfolio Fund Class C stands out by focusing on industries with long-term growth prospects driven by demographic shifts, technological advancement, and rising healthcare needs.

• Fund Family: Saratoga
• Category: Health
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: SHPCX
• Share Class: Health & Biotechnology Porfolio Class C
• Index: S&P 500 TR

Performance

SHPCX had a total return of 23.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.65%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FACDX	Fidelity	Fidelity Advisor Health Care A	0.92%
FACTX	Fidelity	Fidelity Advisor Health Care M	1.23%
FBIOX	Fidelity	Fidelity Select Biotechnology Portfolio	0.60%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.95%
FBTCX	Fidelity	Fidelity Advisor Biotechnology C	1.65%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SBHIX	Class I	2.60%
SHPAX	Class A	3.00%

Top 10 Holdings

50.39% of assets

Name	Symbol	Weight
Amgen Inc.	AMGN	5.93%
Jazz Pharmaceuticals plc	JAZZ	5.69%
United Therapeutics Corporation	UTHR	5.64%
McKesson Corporation	MCK	5.29%
Cardinal Health, Inc.	CAH	5.05%
Exelixis, Inc.	EXEL	4.95%
Regeneron Pharmaceuticals, Inc.	REGN	4.56%
Cencora, Inc.	COR	4.53%
Medpace Holdings, Inc.	MEDP	4.42%
Johnson & Johnson	JNJ	4.32%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 9, 2025	$0.7788	Dec 10, 2025
Dec 10, 2024	$0.2534	Dec 11, 2024
Dec 8, 2023	$1.0202	Dec 11, 2023
Dec 9, 2022	$1.2749	Dec 12, 2022
Dec 10, 2021	$0.7883	Dec 13, 2021
Dec 11, 2020	$2.5794	Dec 11, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Nov 9, 2026

Data Sources Report a data error